Close Menu

NEW YORK (GenomeWeb) – SeraCare Life Sciences and Toma Biosciences announced today that they are entering into a codevelopment partnership.

Terms of the agreement call for SeraCare to provide Toma with access to its Seraseq Solid Tumor Mutation mix reference material technology to support the development and validation of Toma OS-Seq, a comprehensive solid tumor gene analysis kit, and Toma's upcoming PlasmaSeq liquid biopsy test.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

New US Department of Commerce rules will affect supercomputing in China, according to the Wall Street Journal.

A new analysis finds that it will be more than a century until female computer scientists publish at the same rate as their male counterparts, ScienceInsider reports.

Broad Institute researchers describe an approach they've dubbed "DNA microscopy."

In PLOS this week: epigenetic changes following hepatitis C virus treatment, metagenomic analysis of Ugandan children with febrile illness, and more.